Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Group EMDR therapy for ongoing traumatic stress after road traffic accidents

Official title: A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for Ongoing Traumatic Stress in Road Traffic Accident Survivors for Reduction of Post-Traumatic Stress Symptoms

Run by University of the Punjab · NCT07027930 · Data updated 2026-11-12

This trial will try a group EMDR program to see if it reduces post-traumatic stress symptoms, depression, and anxiety and improves quality of life for adults aged 18–45 who had a road traffic accident 3 months to 10 years ago.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment35 (estimated)
SponsorUniversity of the Punjab
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedMay 1, 2025
Main results expectedSeptember 25, 2025
Study endsNovember 1, 2025
Registry record updatedJune 19, 2025
Trial IDNCT07027930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–45 who had a road traffic accident 3 months to 10 years ago, can attend in-person group sessions, and do not have severe psychiatric or neurological conditions.

Probably not a fit

People with schizophrenia or bipolar disorder, those with major neurological/cognitive deficits from severe head injury, or individuals within 3 months of their accident are unlikely to benefit from this protocol as tested here.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will run a randomized controlled feasibility trial of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) delivered at public universities in Lahore. Adults aged 18–45 who experienced a traffic accident between 3 months and 10 years earlier will be randomized to the group intervention or a control condition and assessed at pre-treatment, post-treatment, and one-month follow-up. Outcomes include psychological measures (DASS-21, UIES-R) and quality of life (WHOQOL-BREF), with the primary focus on feasibility and acceptability of the group protocol in a resource-constrained setting. Exclusion criteria include schizophrenia, bipolar disorder, severe head injury with cognitive deficits, or accidents less than 3 months prior.

Why it matters

Potential benefit: If successful, the intervention could provide a scalable group therapy option that reduces trauma symptoms and improves quality of life for traffic-accident survivors.

How similar studies have gone: Individual EMDR has strong evidence for PTSD and some group EMDR formats have shown promising feasibility, but the specific EMDR-IGTP-OTS protocol in this context is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 and 45 years.
* Experienced a traffic accident 3 months to 10 years prior
* Willing to participate and able to understand the intervention components.

Exclusion Criteria:

* Participants will be excluded from the study if they meet any of the following criteria:

  * Diagnosed with conditions such as schizophrenia or bipolar disorder, which require specialized treatment beyond the scope of this study.
  * History of severe head injuries resulting in neurological or cognitive deficits.
  * Participants who have experienced a traffic accident less than 3 months ago, as immediate post-traumatic responses may not have stabilized

Where it's running

  • Public Universities
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Khawer Javed, MS clinical Psychology — Centre for clinical Psychology, University of the Punjab
  • Study coordinator: Khawer Javed, MS clinical Psychology
  • Email: khwr348@gmail.com
  • Phone: +92 3415014715

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.